Whole bladder wall photodynamic thepy (PDT) with haematoporphyrin derivative and an argon dye laser as a light source was performed on 34 patients with refractory carcinoma in situ (CIS) of the bladder.
The behaviour of carcinoma in situ (CIS) of the bladder is variable, and it has been reported that most invasive bladder cancers progress from CIS (Utz et al., 1970; Prout et al., 1983) . Many investigators have performed intravesical administaion of various kinds of cytotoxic agents or bacilhls Calmette-Guerin (BCG). Repeated courses of intravesical BCG or chemotherapeutic agents have been shown to be effective in patients with CIS (Herr et al., 1986; Prout et al., 1987) . However, adverse reactions to such treatments are not negligible (Lamm et al., 1986) , and the risk of invasive (30%) or metastatic (50%) cancer developing exceeds the prospects of eradicating the superficial tumour present with further therapy in patients in whom two or more courses of BCG therapy have failed (Catalona et al., 1987 associated with CIS, six of 11 CR patients had recurrence within 2 years. Two of three dead patients died of other diseases (Figure 3 ). Twenty-five of 34 patients achieved CR and ten of 25 patients with CR after PDT who received TUR of the bladder cancer for recurrent papillary bladder tumours were alive with the bladder intact with a mean observation period of 64.0 months (Table II) . Of the patients who received total cystectomy after PDT, all of those who had initially achieved a CR were alive; in contrast, four of the nine patients in the PR and NC groups died of cancer. The main adverse reactions were haematuria, frequency, skin photosensitivity and decrease in bladder capacity. As shown in Figure 4 , bladder capacity was temporarily reduced to approximately 150-200 ml for 1-2 months after PDT. Complications of whole bladder wall PDT in 34 patients are summarised in Table III not an easy task to compare them, since different drugs were used at different doses and with extrnally measured nonscattered light dosimetry. The mechanism by which PDT induced cytotoxic effects has received much attention (Weishaupt et al., 1976) . The differential retention and/or uptake of photosensitising drug by malignant tissue ultimately is responsible for the preferential destruction of tumour adjacent to normal surrounding tissue. When exposed to light of an appropriate wavelength, photosensitisers, such as HpD, can absorb this energy and become excited, with the potential for transfer of photons to molecular oxygen or relaxation of the drug to its ground state. Absorption of this energy by oxygen results in its transformation to singlet oxygen and other reactive oxygen radicals. The birth of these reactive species culminates in cell death, perhaps through several mechanis. The first cellular changes observed after PDT begin in mitochondria (Berns et al., 1982) with cytocidal effects through the results of damage to the tricarboxylic acid cycle. The PDT-induced vasoconstriction in the tumour endothelium may result in an anoxic state that may also contribute to cell death. In addition, cell membrane damage by these reactive species has been postulated (Henderson et al., 1985) . In our series of patients with CIS, 25 of 34 patients (73.5%) achieved a complete response at 3 months after PDT. Ten patients were alive with the bladder intact more than 5 years after PDT. Nevertheless, recurre within 2 years of follow-up occurred in 14 (77.8%) of the 18 CR patients with CIS. The outcome of PDT in patients with CIS was compared with that of BCG therapy or cytotoxic intravesical instillation therapy. PDT appeared to be the most efficient in immediate therapeutic clinical efficy after the treatment, compared with the clinical effects of BCG and cytotoxic treatment (59% and 35% CR respectively) (Prout et al., 1987; Kavoussi et al., 1988) . However, the recurrence rate within 2 years of PDT was the highest, compared with the recurre rates after BCG and cytotoxic instillation therapy of 39% and 31% respectively. This high recurre rate in PDT should be addressed in future studies. Interestingly, however, most of the tumours recurring after PDT were superficial low-grade papillary tumours which could be controlled by TUR. As an outcome, the bladder was retained in approximately 30% of patients with CIS treated with PDT at a mean follow-up period of 64.0 months. Although the long-term results, as opposed to the short-term responses, might be considered rather disappointing, we would like to emphasise that PDT has clearly had some benefit on the outcome of a number of patients. The main adverse reactions, photosensitivity and decreases in the bladder capacity, are probably caused by retention of HpD in the skin or normal portion of the bladder. The selectivity of HpD is dependent on the longer retention time of HpD in tumorous tissue than in normal tissues. It is important to establish the kinetics of HpD in CIS of the human bladder in order to achieve the maximum effect of PDT in the tumourous portion and minimum adverse reaction in the normal portion. To overcome these adverse reactions, a search for a new photosensitiser, which could accumulate in tumours more efficiently and be excreted from normal tissues more rapidly, is a priority. Phthalocyanine appears to be a candidate as a new photosensitiser based on expenimental data (Komatsu, 1991; Koshida et al., 1993) , concerning cytotoxicity, antitumour effect, kinetics and skin photosensitivity.
